FI  Schooner Capital

     Office Locations:

60 South Street, Suite 1120
Boston, MA 02111
Phone: 617-963-5200
Fax: 617-963-5201



  • Early



  • Information Technology
  • Software & Internet



    Founded in 1971, Schooner Capital, LLC is a private investment firm managing approximately $300 million. A family office headed by Vin Ryan, Schooner has no outside limited partners and approaches all investments with a long-term perspective. Areas of concentration are growth equity investments, alternative assets, and public securities. The firm focuses on U.S.-based companies. The firm also invests in hedge funds, private equity funds, venture capital funds, and other specialized alternative asset structures across sectors and across the globe.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Alexandra Manick Associate Principal
    Antonio Cienfuegos Associate Principal
    Emily Caccam Operations and Foundation Associate
    Jon Corbett Vice President
    Julia Pettengill Executive Director


    Recent Funding Events (trailing 12 months):















      Series A


      Selux Diagnostics



      Series C


    Portfolio companies include:


    Recent News: